General News

Will Women Have Short Memories About Hormone Replacement Therapy? Pharma Hopes So

By (about the author)     Permalink       (Page 1 of 2 pages)
Related Topic(s): ; ; ; ; ; , Add Tags Add to My Group(s)

Must Read 1   Well Said 1  
View Ratings | Rate It

opednews.com Headlined to H2 10/31/12

Become a Fan
  (70 fans)

(Article changed on November 1, 2012 at 19:19)

 It has been almost ten years since a federal study found that hormone replacement therapy (HRT) did not prevent heart disease and memory loss as advertised but increased the risk of heart attacks by 29 percent and doubled the risk of dementia. Oops.

That was not all the bad news that emerged about HRT. It also increased the risk of breast cancer by 26 percent, stroke by 41 percent, doubled the risk of blood clots and increased the risk of hearing loss, gall bladder disease, urinary incontinence, asthma, the need for joint replacement, melanoma, ovarian, endometrial and lung cancers and non-Hodgkin's lymphoma, according to medical journals.


Will women fall for HRT again? by Martha Rosenberg

Not exactly the fountain of youth it was billed as by hormone drug maker Wyeth (now Pfizer) in high-budget menopause awareness TV ads   starring model Lauren Hutton.

In fact, HRT was such a scourge against women, in the first year that millions quit, 2003, the incidence of US breast cancer fell seven percent. It fell 15 percent among women whose tumors were fed by estrogen. Fourteen thousand women who were expected to get breast cancer didn't said news reports. And it wasn't just breast cancer women were spared: heart attack and ovarian cancer rates also fell when women quit HRT, said news reports.

The statistics must have been embarrassing to cancer researchers and public health officials. Not only was a major cause of breast cancer hidden in plain sight, the war on cancer should apparently have been a war on cancer-causing drugs!

It was even more embarrassing because the whole sequence happened before! In 1975, an FDA panel found a link between Premarin (a Wyeth HRT drug) and endometrial cancer and when women quit the drug by the millions--the same thing happened. "There was a sharp downward trend in the incidence of endometrial cancer that paralleled a substantial reduction in prescriptions for replacement estrogens," reported the New England Journal of Medicine (NEJM) in 1979.

Not wanting to lose its billion dollar HRT franchise, Wyeth's medical director wrote doctors in the 1970s that HRT still had "proven benefits" at the "the lowest maintenance dose"   and that it was "simplistic indeed to attribute an apparent increase in the diagnosis of endometrial carcinoma solely to estrogen therapy."

Thirty years later, when cancer rates again dropped, Wyeth rolled out the "timing theory"--a campaign that said women don't need less HRT, they need more. "The benefits of HRT may outweigh the risks if treatment is given to younger women, but the risks may outweigh benefits if treatment is started at a later age," wrote a Wyeth-linked doc in a medical journal in 2004.

Despite the 29 percent increase in heart attacks correlated with HRT, clinical trials of   whether HRT was "cardioprotective" (per the timing theory) were launched at major US medical centers in the mid 2000s. Seven of the study's investigators were Wyeth-linked, though the trials were said to be privately funded.

And despite the doubled risk of dementia correlated with HRT, a timing theory trial exploring if HRT is "neuroprotective" against Alzheimer's Disease was launched, funded by the National Institute on Aging. The New York Times even got into the act, running a magazine article extolling the timing theory ("The Estrogen Dilemma") which its author now admits omitted the Wyeth/Pfizer links of five "experts" cited.

(Nor are animals spared in Pharma's government-abetted efforts to profiteer on women and menopause. Grisly primate experiments into early hormone use are conducted at Wake Forest, Mount Sinai and other medical centers.)

This week a U.S. Preventive Services Task Force reaffirmed the dangers of long-term HRT use. Neither combined estrogen and progestin (as in Wyeth's Prempro) in women without hysterectomies or estrogen alone (as in drugs like Premarin) in women with hysterectomies are safe on a long term basis, said the panel of independent experts after viewing the literature.

Within hours of the report, the hormone franchise bit back. "It is very important that patients understand what this report does not say: it does not recommend against the use of hormone therapy for the relief of menopausal symptoms," commented the HRT-friendly American Society for Reproductive Medicine. Key word "against."

As a new generation of women approach menopause, will the HRT lessons of the 1970s and 2000's be lost amid Pharma's marketing again? END

Next Page  1  |  2

 

Martha Rosenberg is an award-winning investigative pubic health reporter who covers the food, drug and gun industries. Her first book, Born With A Junk Food Deficiency: How Flaks, Quacks and Hacks Pimp The Public Health, is distributed by Random (more...)
 

Share on Google Plus Submit to Twitter Add this Page to Facebook! Share on LinkedIn Pin It! Add this Page to Fark! Submit to Reddit Submit to Stumble Upon

Go To Commenting
The views expressed in this article are the sole responsibility of the author and do not necessarily reflect those of this website or its editors.

Writers Guidelines

Contact Author Contact Editor View Authors' Articles

Most Popular Articles by this Author:     (View All Most Popular Articles by this Author)

Grassley Investigates Lilly/WebMD link Reported by Washington Post

The Drug Store in Your Tap Water

Are You Sure You're Not Psychotic Asks Shameless Drug Company?

It's the Cymbalta Stupid

MRSA and More. Antibiotics Linked to Obesity and Allergies, Too

Another Poorly Regulated "Derivative"--the Antidepressant Pristiq

Comments

The time limit for entering new comments on this article has expired.

This limit can be removed. Our paid membership program is designed to give you many benefits, such as removing this time limit. To learn more, please click here.

Comments: Expand   Shrink   Hide  
2 people are discussing this page, with 2 comments
To view all comments:
Expand Comments
(Or you can set your preferences to show all comments, always)

Any doctor worth his or her salt will not promote ... by Suzana Megles on Thursday, Nov 1, 2012 at 6:37:25 PM
Conventional HRT uses estradiol (one of the three ... by Laura Stein on Friday, Nov 9, 2012 at 10:36:42 AM